WO2006133829A3 - Verwendung von 25-hydroxy-vitamin d3 - Google Patents
Verwendung von 25-hydroxy-vitamin d3 Download PDFInfo
- Publication number
- WO2006133829A3 WO2006133829A3 PCT/EP2006/005400 EP2006005400W WO2006133829A3 WO 2006133829 A3 WO2006133829 A3 WO 2006133829A3 EP 2006005400 W EP2006005400 W EP 2006005400W WO 2006133829 A3 WO2006133829 A3 WO 2006133829A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- prophylaxis
- deficient
- sensitive
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/45—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Verwendung von 25-Hydroxy-Vitamin D3 bei der Herstellung von Formulierungen zur Behandlung und Prophylaxe von defizitären, sensitiven oder hypoaktiven Hautzuständen oder defizitären, sensitiven oder hypoaktiven Zustände von Hautanhangsgebilden, Symptomen der intrinsischen Alterung der Haut und Hautanhangsgebilde, für die Behandlung und Prophylaxe von endogen bedingten Hauterscheinungen, insbesondere degenerativen und/oder entzündlichen Hauterscheinungen, zur Stimulation der Kollagen-, Hyaluronsäure-, Elastinsynthese und Enzymaktivität, zur Stimulation der intrazellulären DNA-Synthese, zur Steigerung der Zellerneuerung und Regeneration der Haut, und zum Schutz und zur Neubildung von dermalen Kapillargefässen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05013131 | 2005-06-17 | ||
EP05013131.7 | 2005-06-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006133829A2 WO2006133829A2 (de) | 2006-12-21 |
WO2006133829A3 true WO2006133829A3 (de) | 2007-11-29 |
Family
ID=36931663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/005400 WO2006133829A2 (de) | 2005-06-17 | 2006-06-07 | Verwendung von 25-hydroxy-vitamin d3 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006133829A2 (de) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0711558A1 (de) * | 1994-10-21 | 1996-05-15 | Unilever Plc | Präparate zur topischen Anwendung auf die Haut, die Haare und die Nägeln |
WO1997009987A1 (fr) * | 1995-09-15 | 1997-03-20 | Centre International De Recherches Dermatologiques Galderma (Cird Galderma) | Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide |
WO2003077861A2 (en) * | 2002-03-13 | 2003-09-25 | Collagenex Pharmaceuticals, Inc. | Water-based delivery systems |
-
2006
- 2006-06-07 WO PCT/EP2006/005400 patent/WO2006133829A2/de active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0711558A1 (de) * | 1994-10-21 | 1996-05-15 | Unilever Plc | Präparate zur topischen Anwendung auf die Haut, die Haare und die Nägeln |
WO1997009987A1 (fr) * | 1995-09-15 | 1997-03-20 | Centre International De Recherches Dermatologiques Galderma (Cird Galderma) | Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide |
WO2003077861A2 (en) * | 2002-03-13 | 2003-09-25 | Collagenex Pharmaceuticals, Inc. | Water-based delivery systems |
Non-Patent Citations (3)
Title |
---|
DATABASE EPODOC EUROPEAN PATENT OFFICE, THE HAGUE, NL; XP002414772 * |
DATABASE EPODOC European Patent Office; XP002414773 * |
DATABASE EPODOC European Patent Office; XP002414774 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006133829A2 (de) | 2006-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007044534A3 (en) | Vegf analogs and methods of use | |
WO2009065857A3 (en) | Compositions for reducing oxidative stress and uses thereof | |
WO2007006307A3 (en) | Novel salts of fumaric acid monoalkylesters and their pharmaceutical use | |
WO2007070850A3 (en) | Skin care compositions and treatments | |
WO2009136291A3 (en) | Cellular extracts | |
WO2009034537A3 (en) | Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid | |
WO2008047150A3 (en) | Protein variants | |
WO2007024899A3 (en) | Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes | |
WO2011053783A3 (en) | Ax213 and ax132 pcsk9 antagonists and variants | |
WO2007016112A3 (en) | Use of adipose tissue-derived stromal cells in spinal fusion | |
WO2007097993A3 (en) | Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor | |
WO2006018836A3 (en) | Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues | |
WO2007082923A3 (de) | Verwendung von protein-microbeads in der kosmetik | |
WO2012072245A3 (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes, hair and/or nails | |
WO2006048242A3 (en) | Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis | |
WO2011027085A3 (fr) | Principe actif issu de candida saitoana et utilisation cosmetique pour la detoxification des cellules de la peau | |
WO2008157483A3 (en) | Polypeptides and methods of use | |
WO2008148891A3 (en) | MC-1R, MC-2R, AND/OR µ OPIOID RECEPTORS STIMULATION | |
WO2006124892A3 (en) | Modulators of alpha-synuclein toxicity | |
WO2010107185A2 (ko) | 배아줄기세포 유래 혈관형성전구세포 배양 분비물 또는 이의 분획물을 포함하는 피부재생용 조성물 및 이의 용도 | |
WO2008008569A3 (en) | Prelamin a pre peptide as a universal stem cell differentiation signal | |
WO2013060771A3 (en) | Composition containing an extract of a sequential or simultaneous fermentation | |
WO2010020424A3 (de) | Verwendung von glucosylglycerol | |
TW200719920A (en) | Topical skin care composition | |
WO2006117465A3 (fr) | Utilisation de polyphenols de cacao pour reguler la pigmentation de la peau |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06754168 Country of ref document: EP Kind code of ref document: A2 |